Rashad Ismayılov

25PUBLICATIONS
89CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersHaematological tumoursClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 30, 2026
Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

|Jun 24, 2026
High prevalence of colistin heteroresistance in Pseudomonas aeruginosa bloodstream isolates and associated clinical factors.

|Jun 15, 2026
Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy eras.

|Jun 12, 2026
Prognostic Implications of Chronic Kidney Disease in Colorectal Cancer Surgery: A Propensity Score-Matched Analysis.

|Apr 13, 2026
RE: An immunosuppressive tertiary lymphoid structure is associated with adverse prognosis in gastric-type endocervical adenocarcinoma.

Rashad Ismayilov, Ozden Altundag

|Mar 09, 2026
Beyond linearity and static risk: re-evaluating core prognostic factors in diffuse large B-cell lymphoma.

Rashad Ismayilov, Murat Ozdede, Yahya Buyukasik

Pageof 5

Frequent Collaborators

7 joint publications

Arif Akyıldız

5 joint publications

Ozden Altundag

4 joint publications

Arzu Oguz

4 joint publications

Zafer Akcali